Process and methods

2 QIPP key therapeutics document

2 QIPP key therapeutics document

2.1 Aims

The aim of the QIPP key therapeutics document is to inform local medicines optimisation activity. The document supports the implementation of NICE guidance either directly or by signposting the NHS to therapeutic evidence or prescribing practice relevant to existing guidance. The QIPP key therapeutics document is reviewed and updated annually.

2.2 Key audiences

The QIPP key therapeutics document is written for NHS professional staff and has the following target audiences:

  • local medicines optimisation services across all areas of the NHS

  • clinicians.

2.3 Key activities

The key activities involved in the production of the QIPP key therapeutics document are:

  • identifying, prioritising and selecting the key therapeutic topics

  • summarising the best available evidence for each topic (usually NICE guidance or other 'high-level' evidence, such as MHRA recommendations, Cochrane reviews, or NICE Medicines and Prescribing Centre evidence summaries or commentaries)

  • signposting to the relevant QIPP prescribing comparator(s) for each topic (where these are available)

  • providing a commentary on variations shown in the prescribing comparators using data provided by the Health & Social Care Information Centre (H&SCIC) and NHS Business Services Authority (NHSBSA).